BTIG Upgrades Histogenics To Buy, Sets $3.50 Price Target
August 12, 2016 at 11:57 AM EDT
BTIG upgraded Histogenics Corp (NASDAQ: HSGX) to Buy from Neutral, suggesting a $3.50 price target on shares. The company continued ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.